Abbott Laboratories buy Stifel Nicolaus
Start price
23.01.25
/
50%
€113.50
Target price
23.01.26
€129.61
Performance (%)
-19.76%
End price
24.01.26
€91.07
Summary
This prediction ended on 24.01.26 with a price of €91.07. The price of Abbott Laboratories has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.76%. Stifel_Nicolaus has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -3.413% | -3.413% | -21.760% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,67 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 14,64 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,74 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 9,34 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Stifel Nicolaus from $130.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten
Current prediction by Stifel_Nicolaus for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€115.06
17.04.25
17.04.25
€127.60
17.04.26
17.04.26
-20.56%
20.03.26
20.03.26
